Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 37 for “"Drug Discrimination"”.

  1. Neuropharmacological Characteristics of Tolerance for Cocaine Used as a Discriminative Stimulus

    … is operationally defined as a decreased drug effect due to prior history of drug administration. The animal model that was chosen to investigate tolerance to cocaine was the drug discrimination model, which is an animal analogue of human subjective drug effects. In the drug discrimination …

    unt Repository record for Neuropharmacological Characteristics of Tolerance for Cocaine Used as a Discriminative Stimulus (opens in a new tab)

  2. Effects of Ethanol on Stimulus Properties of D-Amphetamine

    The drug discrimination paradigm was used to investigate the effects of combinations of d-amphetamine sulfate (amph) and alcohol (etoh). Rats were trained to discriminate between the stimulus properties of 1.2 mg/kg amph and non-drug treatment in a two-lever food-motivated operant task. Once …

    odu Repository record for Effects of Ethanol on Stimulus Properties of D-Amphetamine (opens in a new tab)

  3. ESTABLISHING THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE IN C57BL/6 MICE

    … treat schizophrenia. The present study used the drug discrimination paradigm to measure the subjective effects of the atypical antipsychotic amisulpride and to examine the underlying neuropharmacological mechanisms responsible for the discriminative stimulus property of the drug. Male C57BL/6 …

    vcu Repository record for ESTABLISHING THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE IN C57BL/6 MICE (opens in a new tab)

  4. The Discriminative Stimulus Properties of the Atypical Antipsychotic Ziprasidone in Rats

    Ziprasidone (ZPD) is an atypical antipsychotic drug (APD) that has been shown to fully substitute in C57BL/6 mice for the discriminative stimulus properties of the atypical APD clozapine (CLZ). In rats, however, it has failed to substitute for either 1.25 mg/kg or 5.0 mg/kg training doses of CLZ. …

    vcu Repository record for The Discriminative Stimulus Properties of the Atypical Antipsychotic Ziprasidone in Rats (opens in a new tab)

  5. In vivo and in vitro aspects of imidazoline-2(1/2)sites within the central nervous system

    … binding site were probed using the technique of drug discrimination and receptor autoradiography. Data presented in this thesis indicates the I2 ligand 2-BFI generates a cue in drug discrimination. Further studies indicated agmatine, a proposed endogenous imidazoline ligand, and a number of …

    aston Download PDF for In vivo and in vitro aspects of imidazoline-2(1/2)sites within the central nervous system (opens in a new tab)

  6. Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain

    … cannabimimetic effects were measured in the drug discrimination paradigm. ZCZ011 analogs were either tested alone in these assays to screen for agonist activity or in combination with CB1 orthosteric agonist CP55,940 to screen for PAM effects. ZCZ011 analogs did not exhibit CB1 agonist …

    vcu Repository record for Investigating Cannabinoid Type-1 Receptor (CB1R) Positive Allosteric Modulators (PAMs) in Mouse Models of Overt Cannabimimetic Activity, Subjective Drug Effects, and Neuropathic Pain (opens in a new tab)

  7. CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE IN C57BL/6 MICE

    … derivative, is an atypical antipsychotic drug used to treat both schizophrenia and depression. Amisulpride is a selective antagonist at dopamine D2 and D3 receptors and at serotonin 5-HT2B and 5-HT7 receptors and displays an atypical clinical profile with reduced extrapyramidal motor …

    vcu Repository record for CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE IN C57BL/6 MICE (opens in a new tab)

  8. A COMPARISON OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC CLOZAPINE AND THE GLUTAMATE AGONIST N-METHYL D-ASPARTATE IN C57BL/6 MICE.

    … N-methyl D-aspartate (NMDA) in rats, NMDA discrimination has not previously been established in mice. The present study was designed to explore the possible role of NMDA activity in clozapine’s discriminative stimulus. Two groups of C57BL/6 mice were trained to discriminate either 2.5 mg/kg …

    vcu Repository record for A COMPARISON OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC CLOZAPINE AND THE GLUTAMATE AGONIST N-METHYL D-ASPARTATE IN C57BL/6 MICE. (opens in a new tab)

  9. Determinants of Abuse-Related Effects of Monoamine Releasers in Rats

    … rats: intracranial self-stimulation (ICSS) and drug discrimination. First, this work confirmed and expanded upon previous findings that selectivity for promoting release of dopamine versus serotonin is one determinant of abuse-related effects produced by monoamine releasers. This was …

    vcu Repository record for Determinants of Abuse-Related Effects of Monoamine Releasers in Rats (opens in a new tab)

  10. The Discriminative Stimulus Properties of the Atypical Antipsychotic Clozapine in C57BL/6 Mice

    … may contribute to atypical antipsychotic drug effects. Clozapine (2.5 mg/kg) drug discrimination in C57BL/6 mice may selectively screen atypical antipsychotic drugs. Previous data show that the atypical antipsychotics olanzapine, risperidone, ziprasidone but not the typical antipsychotic …

    vcu Repository record for The Discriminative Stimulus Properties of the Atypical Antipsychotic Clozapine in C57BL/6 Mice (opens in a new tab)

  11. Discriminative Stimulus Properties of Endogenous Cannabinoid Degradative Enzyme Inhibitors

    … for Δ9-tetrahydrocannabinol (THC) in drug discrimination procedures. However, combined inhibition of both enzymes fully substitutes for THC, as well as produces a full constellation of cannabimimetic effects. Because no published report to date have investigated whether an inhibitor of …

    vcu Repository record for Discriminative Stimulus Properties of Endogenous Cannabinoid Degradative Enzyme Inhibitors (opens in a new tab)

  12. Acquisition and Generalization of a Positive-Feature Interoceptive Morphine Occasion Setter Across Sex and Estrous Phase in Rats

    Drug stimuli can be trained as a positive-feature (FP) occasion setters (OS) that disambiguate the relation between a conditioned stimulus (CS) and an unconditioned stimulus (US). Females were previously found to be less sensitive to generalization of a FP morphine OS than males, so the role of …

    guelph Repository record for Acquisition and Generalization of a Positive-Feature Interoceptive Morphine Occasion Setter Across Sex and Estrous Phase in Rats (opens in a new tab)

  13. Behavioral Assessment and HPLC/MS/MS Identification of the Synthetic Cannabinoid, CP47,497, in Mice

    … compounds have resurfaced in the designer drug market, marketed as “herbal incense products” (HIPs). Their popular use has resulted in an alarming rate of reported adverse effects and toxicities. Current legislation classified CP47,497 and several other synthetic cannabinoids compounds as …

    vcu Repository record for Behavioral Assessment and HPLC/MS/MS Identification of the Synthetic Cannabinoid, CP47,497, in Mice (opens in a new tab)

  14. BEHAVIORAL PHENOTYPING OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC DRUG CLOZAPINE IN 129S2/HSV MICE

    … and interpretation of the in vivo effects of drugs. The drug discrimination assay measures the subjective effects of drugs and provides a measure of underlying neuropharmacological mechanisms responsible for the discriminative stimulus properties of drugs. The present study established the …

    vcu Repository record for BEHAVIORAL PHENOTYPING OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC DRUG CLOZAPINE IN 129S2/HSV MICE (opens in a new tab)

  15. The Non-Discrimination Between Nicotine and Cigarette Smoke Extract in Male and Female Rats

    … to tobacco use disorder. Using a Pavlovian drug discrimination task, we hypothesized that rats would discriminate between nicotine-alone and in cigarette smoke extract (CSE) based on the presence of constituent chemicals. Behaviour is assessed using three types of occasion setting training: …

    guelph Repository record for The Non-Discrimination Between Nicotine and Cigarette Smoke Extract in Male and Female Rats (opens in a new tab)

  16. Design, Synthesis, and Pharmacological Characterization of Serotonin (5-HT) 5-HT2C Receptor (5-HT2CR) Positive Allosteric Modulators

    … health issues such as impulsivity disorders, drug addiction, depression, schizophrenia, and obesity. Therefore, restoration of the diminished signaling capacity through 5-HT2CR activation has therapeutic potential. A series of new molecules based on the 4-alkylpiperidine-2- carboxamide …

    utmb Repository record for Design, Synthesis, and Pharmacological Characterization of Serotonin (5-HT) 5-HT2C Receptor (5-HT2CR) Positive Allosteric Modulators (opens in a new tab)

  17. Effect of SA 4503 on the locomotor stimulatory and discriminative stimulus properties of psychostimulants

    … methamphetamine-induced hyperactivity. In the drug discrimination study, SA 4503 pretreatment augmented the effect of methamphetamine to substitute for the methamphetamine and cocaine discriminative stimuli. Our findings suggest sigma receptors mediate the locomotor stimulatory properties, and …

    missouri Repository record for Effect of SA 4503 on the locomotor stimulatory and discriminative stimulus properties of psychostimulants (opens in a new tab)

  18. Searching for new analgesics without addiction risks

    … to the classical MOR antagonist naltrexone, in drug discrimination studies in order to better understand its subjective effects and more thoroughly its abuse liability. IBNtxA represents an intriguing lead compound for preclinical drug development specifically targeting MOR splice variants, …

    rowan Repository record for Searching for new analgesics without addiction risks (opens in a new tab)

  19. Effects of (R,S)-ketamine and (2R,6R)-hydroxynorketamine: a preclinical study

    … findings indicate potential for glutamatergic drugs like (R,S)-ketamine and (2R,6R) hydroxynorketamine to produce more rapid and longer-acting therapeutic effects. The antidepressant effectiveness of (R,S)-ketamine for many patients is undisputed; however, the antidepressant efficacy of the …

    vcu Repository record for Effects of (R,S)-ketamine and (2R,6R)-hydroxynorketamine: a preclinical study (opens in a new tab)

Page 1 of 2